Maroui MA - Search Results

1

Small Ubiquitin-like Modifier Alters IFN Response.

Maarifi G, Maroui MA, Dutrieux J, Dianoux L, Nisole S, Chelbi-Alix MK. Maarifi G, et al. Among authors: maroui ma. J Immunol. 2015 Sep 1;195(5):2312-24. doi: 10.4049/jimmunol.1500035. Epub 2015 Jul 29. J Immunol. 2015. PMID: 26223657

2

[Implication of PML nuclear bodies in intrinsic and innate immunity].

Maroui MA, El Asmi F, Dutrieux J, Chelbi-Alix MK, Nisole S. Maroui MA, et al. Med Sci (Paris). 2014 Aug-Sep;30(8-9):765-71. doi: 10.1051/medsci/20143008014. Epub 2014 Sep 1. Med Sci (Paris). 2014. PMID: 25174753 Free article. Review. French.

3

Differential effects of SUMO1 and SUMO3 on PKR activation and stability.

Maarifi G, El Asmi F, Maroui MA, Dianoux L, Chelbi-Alix MK. Maarifi G, et al. Among authors: maroui ma. Sci Rep. 2018 Jan 19;8(1):1277. doi: 10.1038/s41598-018-19683-6. Sci Rep. 2018. PMID: 29352251 Free PMC article.

4

Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.

Maroui MA, Maarifi G, McManus FP, Lamoliatte F, Thibault P, Chelbi-Alix MK. Maroui MA, et al. Mol Cell Proteomics. 2018 Jun;17(6):1196-1208. doi: 10.1074/mcp.RA117.000447. Epub 2018 Mar 13. Mol Cell Proteomics. 2018. PMID: 29535160 Free PMC article.

5

TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.

El-Asmi F, El-Mchichi B, Maroui MA, Dianoux L, Chelbi-Alix MK. El-Asmi F, et al. Among authors: maroui ma. Cytokine. 2019 Aug;120:264-272. doi: 10.1016/j.cyto.2019.05.008. Epub 2019 May 29. Cytokine. 2019. PMID: 31153006

6

SUMOylation promotes PML degradation during encephalomyocarditis virus infection.

El McHichi B, Regad T, Maroui MA, Rodriguez MS, Aminev A, Gerbaud S, Escriou N, Dianoux L, Chelbi-Alix MK. El McHichi B, et al. Among authors: maroui ma. J Virol. 2010 Nov;84(22):11634-45. doi: 10.1128/JVI.01321-10. Epub 2010 Sep 8. J Virol. 2010. PMID: 20826694 Free PMC article.

7

Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.

Maroui MA, Kheddache-Atmane S, El Asmi F, Dianoux L, Aubry M, Chelbi-Alix MK. Maroui MA, et al. PLoS One. 2012;7(9):e44949. doi: 10.1371/journal.pone.0044949. Epub 2012 Sep 18. PLoS One. 2012. PMID: 23028697 Free PMC article.

8

Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.

Maroui MA, Pampin M, Chelbi-Alix MK. Maroui MA, et al. J Virol. 2011 Dec;85(24):13164-73. doi: 10.1128/JVI.05808-11. Epub 2011 Oct 12. J Virol. 2011. PMID: 21994459 Free PMC article.

9

Differential Roles of PML Isoforms.

Nisole S, Maroui MA, Mascle XH, Aubry M, Chelbi-Alix MK. Nisole S, et al. Among authors: maroui ma. Front Oncol. 2013 May 22;3:125. doi: 10.3389/fonc.2013.00125. eCollection 2013. Front Oncol. 2013. PMID: 23734343 Free PMC article.

10

Implication of PMLIV in both intrinsic and innate immunity.

El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK. El Asmi F, et al. Among authors: maroui ma. PLoS Pathog. 2014 Feb 27;10(2):e1003975. doi: 10.1371/journal.ppat.1003975. eCollection 2014 Feb. PLoS Pathog. 2014. PMID: 24586174 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters